A New Clinical Scale for the Staging of Dementia

1982/06/01 by Charles P. Hughes, Leonard van den Berg, Leonard Berg +4 · 59 citations
Medicine · Economics, Econometrics and Finance · #Dementia and Cognitive Impairment Research #Health Systems, Economic Evaluations, Quality of Life

paper · doi:10.1192/bjp.140.6.566

Abstract

Accurate clinical staging of dementia in older subjects has not previously been achieved despite the use of such methods as psychometric testing, behavioural rating, and various combinations of simpler psychometric and behavioural evaluations. The Clinical Dementia Rating (CRD), a global rating device, was developed for a prospective study of mild senile dementia--Alzheimer type (SDAT). Reliability, validity, and correlational data are discussed. The CRD was found to distinguish unambiguously among older subjects with a wide range of cognitive function, from healthy to severely impaired.

Citations

• The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

Cited by

• Implications of an Advice-Giving and Teacher Role on Language Production in Adults With Dementia
• Cerebral Small Vessel Disease-Induced Apolipoprotein E Leakage Is Associated With Alzheimer Disease and the Accumulation of Amyloid β-Protein in Perivascular Astrocytes
• Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease
• Dementia: The leading predictor of death in a defined elderly population
• A task to assess behavioral pattern separation (BPS) in humans: Data from healthy aging and mild cognitive impairment
• Predictors of Nursing Home Admission for Persons with Dementia
• Precision estimates of longitudinal brain aging capture unexpected individual differences in one year
• Ambient Air Pollution and the Severity of Alzheimer Disease Neuropathology
• Riemannian tangent space mapping and elastic net regularization for cost-effective EEG markers of brain atrophy in Alzheimer's disease
• Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer’s disease
• The BrainLat project, a multimodal neuroimaging dataset of neurodegeneration from underrepresented backgrounds
• Assessment of the severely impaired patient: Description and validation of a new neuropsychological test battery.
• The Mini-Cog: a cognitive ?vital signs? measure for dementia screening in multi-lingual elderly
• Bright light therapy and melatonin in motor restless behaviour in dementia: a placebo-controlled study
• Nomogram for sample size calculation on a straightforward basis for the kappa statistic
• Higher Total Omega-3 PUFA Levels and a Lower Omega-6:Omega-3 Ratio Are Associated with Lower Temporal Lobe Volume in Alzheimer’s Disease
• A Scoping Review on Conversational Memory and Characteristics of Conversations in Alzheimer's Disease
• Precision brain morphometry using cluster scanning
• Synergistic associations of depression and apolipoprotein E genotype with incidence of dementia
• Validation of Spatial Orientation Screening questionnaire for use in memory clinic patients
• Machine Learning for Health: Personalized Models for Forecasting of Alzheimer Disease Progression
• Mobilization-Observation-Behavior-Intensity-Dementia Pain Scale (MOBID): Development and Validation of a Nurse-Administered Pain Assessment Tool for Use in Dementia
• On estimation in the nested case‐control design under nonproportional hazards
• Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer’s disease
• Double-Edged Sword: A Positive Brain Scan Result Heightens Confidence in an Alzheimer’s Diagnosis But Also Leads to Higher Stigma Among Older Adults in a Vignette-Based Experiment
• A survey study of Alzheimer’s stigma among Black adults: intersectionality of Black identity and biomarker diagnosis
• <scp>ICU</scp> Delirium Patterns and 30‐Day Mortality in Critically Ill Adults
• Frequency power and coherence of electroencephalography are correlated with the severity of Alzheimer's disease: A multicenter analysis in Taiwan
• Technological advances enabling an enhanced understanding of early Alzheimer's disease
• Biological Age and Age Acceleration Predict Alzheimer’s Disease Plasma Biomarker Levels
• Effects of caregiving experience on expectations of becoming an Alzheimer’s disease caregiver in the future
• Speech pause distribution as an early marker for Alzheimer’s disease
• Modeling Disease Progression in Mild Cognitive Impairment and Alzheimer's Disease with Digital Twins
• Estimating effects of longitudinal modified treatment policies (LMTPs) on rates of change in health outcomes
• Influence of leisure activity on the incidence of Alzheimer's disease. [europepmc]
• Medial temporal lobe function and structure in mild cognitive impairment. [europepmc]
• White matter lesions impair frontal lobe function regardless of their location. [europepmc]
• Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. [europepmc]
• Aggregation of vascular risk factors and risk of incident Alzheimer disease. [europepmc]
• Mediterranean diet and risk for Alzheimer's disease. [europepmc]
• Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. [europepmc]
• 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. [europepmc]
• Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years. [europepmc]
• Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study. [europepmc]
• Mediterranean diet and mild cognitive impairment. [europepmc]
• Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. [europepmc]
• Blueberry supplementation improves memory in older adults. [europepmc]
• High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic Mild Cognitive Impairment. [europepmc]
• Relationship between education and dementia: an updated systematic review. [europepmc]
• The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: a community-based study. [europepmc]
• A task to assess behavioral pattern separation (BPS) in humans: Data from healthy aging and mild cognitive impairment. [europepmc]
• The epidemiology of frontotemporal dementia. [europepmc]
• Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease. [europepmc]
• Validation of the 4AT, a new instrument for rapid delirium screening: a study in 234 hospitalised older people. [europepmc]
• The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease. [europepmc]
• Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. [europepmc]
• Molecular characterization of selectively vulnerable neurons in Alzheimer's disease. [europepmc]
• Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. [europepmc]
• Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. [europepmc]

Related

• Staging Dementia Using Clinical Dementia Rating Scale Sum of Boxes Scores
• A New Scale for the Assessment of Functional Status in Alzheimer's Disease and Related Disorders
• Cognitive Markers Preceding Alzheimer's Dementia in the Healthy Oldest Old
• The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects
• The Global Deterioration Scale for assessment of primary degenerative dementia